DNA synthesis and depletion of prolactin in the pituitary gland of the male rat.
Haloperidol, bromocriptine and diethylstilboestrol dipropionate were given in various régimes to male rats to determine their effects on pituitary DNA synthesis, prolactin secretion and growth hormone secretion. Haloperidol increased serum prolactin but did not stimulate pituitary DNA synthesis or reduce pituitary prolactin concentrations. Haloperidol potentiated the effects of oestrogen on serum prolactin and on pituitary DNA synthesis; pituitary prolactin concentrations were greatly reduced, and growth hormone secretion was slightly inhibited. The inhibitory effects of bromocriptine in oestrogen-stimulated rats were demonstrated by smaller pituitary weights and decreased DNA synthesis; serum prolactin levels were lowered and pituitary prolactin concentrations were increased. Haloperidol, given to rats treated with oestrogen and bromocriptine, reversed the inhibitory effects of bromocriptine on DNA synthesis and serum prolactin; pituitary prolactin concentrations fell to well below normal. The results suggest that the haloperidol potentiation of oestrogen-induced pituitary DNA synthesis may depend upon stimulation of prolactin secretion together with reduction of intracellular prolactin levels.
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D004054:Diethylstilbestrol / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects
D001971:Bromocriptine; D004054:Diethylstilbestrol; D011388:Prolactin; D013006:Growth Hormone; D004247:DNA; D006220:Haloperidol